Effect of different dose schedules of 0.15% unoprostone isopropyl on intraocular pressure and pupil size in the glaucomatous beagle

Journal of Ocular Pharmacology and Therapeutics

Volumn 20, Issue 5, 2004, Pages 411-420

  Gelatt, Kirk N ^a,b   Mackay, Edward O ^a   Dashiell, Thomas ^a   Biken, Alison ^a  

^a University of Florida College of Veterinary Medicine   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

UNOPROSTONE ISOPROPYL ESTER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CIRCADIAN RHYTHM; CONTROLLED STUDY; DOG; DRUG DOSE REGIMEN; DRUG EFFECT; FEMALE; GLAUCOMA; INTRAOCULAR PRESSURE; MALE; MIOSIS; NONHUMAN; PUPIL;

ANIMALS; ANTIHYPERTENSIVE AGENTS; DINOPROST; DOG DISEASES; DOGS; DRUG ADMINISTRATION SCHEDULE; FEMALE; GLAUCOMA, OPEN-ANGLE; INTRAOCULAR PRESSURE; MALE; PUPIL; TONOMETRY, OCULAR;

EID: 7444230876     PISSN: 10807683     EISSN: None     Source Type: Journal    
DOI: 10.1089/jop.2004.20.411     Document Type: Article

References (36)

1. Soltau, J.B., and Zimmerman, T.J. Changing paradigms in the medical treatment of glaucoma. Sur. Ophthalmol. 47:S2-S5, 2002.
2. Higginbotham, E.J. Editorial: Will latanoprost be the 'wonder' drug of the '90s for the treatment of glaucoma? Arch. Ophthalmol. 114:998-999, 1996.
3. Wyse, T.B., Talluto, D.M., Krupin, T., et al. Topical prostaglandins for glaucoma therapy. J. Glaucoma 6:180-187, 1997.
4. Alm, A., and Stjernschantz, J. Effects on intraocular pressure and side effects of 0.005% latanoprost applied once-daily, evening or morning. Ophthalmology 102:1743-1752, 1995.
5. Gandolfi, S., Simmons, S.T., Sturm, R., et al. Three-month comparison of bimatoprost and latanoprost in patients with glaucoma and ocular hypertension. Adv. Ther. 18:110-121, 2001.
6. Eisenberg, D.L., Toris, C.B., and Camras, C.B. Bimatoprost and travoprost: A review of recent studies of two new glaucoma drugs. Sur. Ophthalmol. 47(suppl.):S105-S115, 2002.
7. Orengo-Nania, S., Landry, T., Von Tress, M., et al. Evaluation of ttravoprost as adjunctive therapy in patients with uncontrolled intraocular pressure while using timolol 0.5%. Am. J. Ophthalmol. 132:860-868, 2001.
8. Lama, P.J. Systemic adverse effects of beta-adrenergic blockers: An evidence-based assessment. Am. J. Ophthalmol. 134:749-760, 2002.
9. Zhan, G.L., Toris, C.B., Camras, C.B., et al. Prostaglandin-induced iris color darkening. Arch. Ophthalmol. 116:1065-1068, 1998.
10. Selen, G., Stjernschantz, J., and Resul, B. Prostaglandin-induced iridal pigmentation in primates. Sur. Ophthalmol. 41(suppl.):S125-S128, 1997.
11. Zhan, G.L., Toris, C.B., Camras, C.B., et al. Prostaglandin-induced iris color darkening. Arch. Ophthalmol. 116:1065-1068, 1998.
12. Taniguchi, T., Haque, M.S., Sugiyama, K., et al. Ocular hypotensive mechanism of topical isopropyl unoprostone. A novel prostaglandin metabolite-related drug, in rabbits. J. Ocul. Pharmacol. Ther. 12:489-498, 1996.
13. Saito, M., Takano, R., Shirato, S. Effects of latanoprost and unoprostone when used alone or in combination for open-angle glaucoma. Am. J. Ophthalmol 132:485-489, 2001.
14. 2-∝ analog, latanoprost, and unoprostone isopropyl. J. Glaucoma 10:487-492, 2001.
15. Tsukamoto, H., Mishima, H.K., Kitazawa, Y., et al. A comparative clinical study of latanoprost and isopropyl unoprostone in Japanese patients with primary open-angle glaucoma and ocular hypertension. J. Glaucoma 11:497-501, 2002.
16. Jampel, H.D., Bacharach, J., Sheu, W.P., et al. Randomized clinical trial of latanoprost and unoprostone in patients with elevated intraocular pressure. Am. J. Ophthalmol. 134:863-871, 2002.
17. Serle, J.B., Podos, S.M., Kitazawa, Y., et al. A comparative study of latanoprost (Xalatan) and isopropyl unoprostone (Rescula) in normal and glaucomatous monkey eyes. Jpn. Ophthalmol. Soc. 42:95-100, 1998.
18. Taniguchi, T., Haque, M.S., Sugiyama, K., et al. Ocular hypotensive mechanism of topical isopropyl unoprostone: A novel prostaglandin metabolite-related drug, in rabbits. J. Ocul. Pharmacol. Ther. 12:489-498, 1996.
19. Ofri, R., Raz, D., Kass, P.H., et al. The effect of 0.12% unoprostone isopropyl (rescula) on intraocular pressure in normotensive dogs. J. Vet. Med. Sci. 62:1313-1315, 2000.
20. Gelatt, K.N., and MacKay, E.O. Effect of different dose schedules of latanoprost on intraocular pressure and pupil size in the glaucomatous Beagle. Vet. Ophthalmol. 4:283-288, 2001.
21. Gelatt, K.N., and MacKay, E.O. Effect of different dose schedules of bimatoprost on intraocular pressure and pupil size in the glaucomatous Beagle. J. Ocul. Pharmacol. Ther. 18:525-534, 2002.
22. Gelatt, K.N., and MacKay, E.O. Effect of different dose schedules of travoprost on intraocular pressure and pupil size in the glaucomatous Beagle. Vet. Ophthalmol. 24:53-57, 2001.
23. 2-∝ isopropyl ester on intraocular pressure in normotensive and glaucomatous canine eyes. J. Ocul. Pharmacol. 7:107-116, 1991.
24. 2α isopropyl ester versus Iloprost phenacyl ester in rabbit and Beagle eyes. Curr. Eye Res. 8:131-138, 1989.
25. Studer, M.E., Martin, C.L., and Stiles, J. Effects of 0.005% latanoprost solution on intraocular pressure in healthy dogs and cats. Am. J. Vet. Res. 61:1220-1224, 2000.
26. Bito, L.Z. Prostaglandins: A new approach to glaucoma management with a new intriguing side effect. Surv. Ophthalmol. 41 (suppl. 2):S1-S14, 1997.
27. Bito, L.Z., Camras, C.B., Gum, G.G., et al. The ocular hypotensive effects and side effects of prostaglandins on the eyes of experimental animals. In: The Ocular Effects of Prostaglandins and Other Eicosanoids. Bito, L.Z., and Stjernschantz, J., eds. New York: Alan R. Liss, 1989:349-368.
28. Bito, L.Z., Fraga, A., Blanco, J., et al. Long-term maintenance of reduced intraocular pressure by daily or twice-daily topical application of prostaglandins to cat or Rhesus monkey eyes. Invest. Ophthalmol. Vis. Sci. 24:312-319, 1983.
29. 2 increases uveoscleral outflow and trabecular outflow facility in the cat. Exp. Eye Res. 61:649-657, 1995.
30. 2α on uveoscleral outflow and outflow facility in the rabbit eye. Exp. Eye Res. 54:277-283, 1992.
31. SAS/STAT. Guide for personal computers, Version 6 ed. Cary, NC:SAS Institute, Inc., 2002.
32. Yoshitomi, T., and Ito, Y. Effects of indomethacin and prostaglandins on the dog iris sphincter and dilator muscles. Invest. Ophthalmol. Vis. Sci. 29:127-132, 1988.
33. Lu, W., Okamura, T., Bian, K., et al. Prostaglandins involved in contractions by angiotension II and bradykinin of isolated dog sphincter pupillae. Br. J. Pharmacol. 95:544-550, 1988.
34. Susanna, R., Giampani, J., Borges, A.S., et al. A double-masked, randomized, clinical trail comparing latanoprost to unoprostone in patients with open-angle glaucoma or ocular hypertension. Ophthalmology 108:259-263, 2001.
35. Sponsel, W.E., Paris, G., Trigo, Y., et al. Comparative effects of latanoprost (Xalatan) and unoprostone (Rescula) in patients with open-angle glaucoma and suspected glaucoma. Am. J. Ophthalmol. 134:552-559, 2002.
36. Susanna, R., Chew, P., and Kitazawa, Y. Current status of prostaglandin therapy: Latanoprost and unoprostone. Sur. Ophthalmol. 47(suppl. 1):S97-S104, 2002.